Viewing Study NCT00673920


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT00673920
Status: TERMINATED
Last Update Posted: 2020-12-04
First Post: 2008-05-05
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Sponsor: Genentech, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04-24
Start Date Type: ACTUAL
Primary Completion Date: 2009-10-26
Primary Completion Date Type: ACTUAL
Completion Date: 2009-10-26
Completion Date Type: ACTUAL
First Submit Date: 2008-05-05
First Submit QC Date: None
Study First Post Date: 2008-05-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-08-27
Results First Submit QC Date: None
Results First Post Date: 2020-12-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2013-07-04
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2020-11-10
Last Update Post Date: 2020-12-04
Last Update Post Date Type: ACTUAL